Supplementary Figure 2. Honokiol suppresses cancer cell stemness, migration, and invasion of 5637 cells. A, ALDH
High cell population (stem and progenitor cells) assessed by flow cytometric analysis in 5637 cells treated with 9.6 µg/ml honokiol for 24 h. Diethylaminobenzaldehyde (DEAB), an ALDH-specific inhibitor, was used as a negative control. B, Cell migration capacity examined by the wound healing assay. Relative wound closure percentage at 24 h was normalized by the gap distance at 0 h. Vertical dotted lines indicate the wound formed at 0 h (top row) and 24 h (bottom row). C, Cell invasive capacity was detected by the Transwell assay. Representative photograph of the transwell inserts with invasive cells at 20× magnification. ***, P < 0.001, compared with the vehicle-treated group indicated as "0". were detected. *, P < 0.05, **, P < 0.01, ***, P < 0.001.
Supplementary

Supplementary Figure 4. Expression of Pou5f1
and Nanog in stem/progenitor cell population of T24 cells. Pou5f1 and Nanog mRNA levels in T24 tumor sphere (stem/progenitor cell population) and T24 cells re-attached on cell plates (differentiated cell population) by quantitative RT-PCR. Pou5f1 and Nanog mRNA levels in T24 parental cells under regular culture condition (adherent) was used as the normalization control.
Supplementary Figure 5. Expression changes of miR-1 and miR-34a upon treatment of honokiol.
The expression levels of negative control (miR-1) and positive control (miR-34a) were examined in 9.6 µg/ml honokiol-treated T24 and 5637 cells for 24 h. **, P < 0.01.
Supplementary Table 1. Sequences of primers for qRT-PCR and ChIP assays Genes Direction Primer sequences qRT-PCR for mRNA
5'-TGTCAGTTTGTCAAATACCCCA-3' miR-34a 5'-TGGCAGTGTCTTAGCTGGTTGT -3' miR-378 5'-ACTGGACTTGGAGTCAGAAG-3' miR-378* 5'-CTCCTGACTCCAGGTCCTGT-3' miR-499 5'-TTAAGACTTGCAGTGATGTT-3' miR-9 5'-TCTTTGGTTATCTAGCTGTATGA-3' miR-96 5'-TTTGGCACTAGCACATTTTTGC-3' ChIP assay Region 1
Forward 5'-TACTCCCATCATCATGCAAA-3'
